SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-24-004642
Filing Date
2024-08-09
Accepted
2024-08-09 16:07:16
Documents
2
Period of Report
2024-08-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 7993
2 EXHIBIT 24 exh_24.htm EX-24 8811
  Complete submission text file 0001171843-24-004642.txt   18316
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address COMPASS THERAPEUTICS, INC. 80 GUEST STREET, SUITE 601 BOSTON MA 02135
Business Address
Anderman Jonathan (Reporting) CIK: 0002032625 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39696 | Film No.: 241192765